NTI secures strategic Cultivation partnership to grow and maintain its medical cannabis
Finfeed Archived Mar 09, 2021
Neurotech International Limited (ASX: NTI) has announced a strategic cultivation partnership with CannaPacific Limited to grow and maintain genetic stock and assist in the development of elite varietal strains through their exclusive licencing agreement.
NTI Days Away from Crucial Lab Results – Can its Cannabis Strain Treat Autism?
Catalyst Hunter Archived Dec 16, 2020
Neurotech International Ltd (ASX: NTI) is focused on the clinical applications of unique cannabis strains to treat neurological disorders such as autism and is set to commence human clinical trials early in 2021.